Abstract
Purpose:
To investigate a cluster of corneoscleral rim cultures positive for Achromobacter species over a 6-month period at Massachusetts Eye and Ear.
Methods:
An increased rate of positive corneal donor rim cultures was noted at Massachusetts Eye and Ear between July and December 2017. Positive cultures were subjected to identification and antimicrobial susceptibility testing by phenotypic (MicroScan WalkAway) and genotypic (16S rDNA sequencing) methods. Samples of the eye wash solution (GeriCare) used in the eye bank were also evaluated. Antimicrobial activity of Optical-GS against Achromobacter spp. at 4°C and 37°C was assessed by time-kill kinetics assay.
Results:
Of 99 donor rims cultured, 14 (14.1%) grew bacteria with 11 (78.6%) due to uncommon nonfermenting Gram-negative bacilli. These had been identified by standard automated methods as Achromobacter (n = 3), Alcaligenes (n = 3), Ralstonia (n = 2), Pseudomonas (n = 2), and Stenotrophomonas (n = 1). Eight of these 11 isolates were subsequently available for molecular identification, and all were identified as Achromobacter spp. Six bottles of eyewash solution were evaluated and were positive for abundant Achromobacter spp. (3.4 × 105 ± 1.1 CFU/mL). Optisol-GS had no bactericidal activity against Achromobacter spp. at 4°C after 24-hour incubation but was bactericidal at 37°C. None of the patients who had received the contaminated corneas developed postoperative infection.
Conclusions:
An eyewash solution arising from a single lot was implicated in the contamination of donor rims by Achromobacter spp. The isolates were able to survive in the Optisol-GS medium at the recommended storage temperature. This highlights the need to continue improving protocols for tissue preparation and storage.
Keywords: endophthalmitis, keratitis, corneoscleral rims, Achromobacter spp
Postoperative keratitis and endophthalmitis are uncommon yet feared complications of corneal transplantation which can result in severe ocular morbidity.1 In some cases, the source of the infecting organism is contamination from the donor cornea.2–4 The Eye Bank Association of America (EBAA) standards include recommendations to decrease the contamination rates during tissue preparation and storage.5 Despite many modifications made by EBAA in the 1990s to better control donor tissue microbial contamination, this problem has not been completely eliminated.
Although the prognostic value of routine surveillance cultures has been debated, microbiological cultures of tissue medium and the remaining scleral rims are often performed.6 Bacterial contamination is most common, with rates ranging from 4% to 14%, and Staphylococcus spp., Propionibacterium acnes, Streptococcus spp., and Pseudomonas aeruginosa are the species most commonly identified.6–9 Fungal contamination rates range from 1.2% to 8.6%, with Candida spp. frequently identified.10,11 There are many potential contamination sources other than the donor eyes, particularly at the tissue-processing and storage levels.12–14 In this study, we investigated a cluster of corneoscleral rims positive for Achromobacter spp., nonfermenting Gram-negative bacilli (NF-GNB), identified for more than a 6-month period at the Massachusetts Eye and Ear (MEE). A likely common source of contamination was a particular lot of eyewash solution used to rinse the eye globe during tissue processing in the eye bank.15
MATERIALS AND METHODS
Corneoscleral Donor Rims and Eyewash Solution Cultures
Bacterial isolates used in this study were routinely collected and frozen in our clinical microbiology laboratory. Protocols for obtaining these isolates were approved by the MEE Institutional Review Board (protocol number: 2019P001001). Isolates were recovered from corneoscleral donor rim cultures performed between July and December 2017. During this period, 99 donor tissues were cultured on chocolate agar and in meat broth for 7 days at 37°C with 5% CO2. Aliquots of 100 μL collected from 6 bottles of the implicated eyewash solution (GeriCare Eye Wash; Kareway Products, Inc) were cultured on blood agar and chocolate agar and incubated under the above-described similar conditions. To determine the bacterial loads and the stability of the microbial biomass in the contaminated solution stored at room temperature as recommended, we performed quantitative cultures weekly over an 8-week period, by plating serial dilutions of the eyewash solution on blood agar.
Microbial Characterization
Positive cultures were speciated, and antimicrobial susceptibility was determined using the MicroScan WalkAway system (Beckman Coulter, Brea, CA) following the manufacture’s protocol. Species identification was validated and refined by sequencing the entire 16S rDNA gene. To do this, the 16S sequence was amplified in a 25-μL reaction using the Kapa HiFi HotStart Ready Mix (Roche, Indiana, IN) and primers16S-8F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 16-1493R (5′-ACGGCTACCTTGTTACGACTT-3′). In addition, primers 16S-743F (5′-CGAAGACTGACGCTCAG-3′) and 16S-777R (5′-GGGTATCTAATCCTGTTTGC-3′) were used for sequencing. DNA molecules were sequenced by the Sanger method by Genewiz, Inc (South Plainfield, NJ).
Minimum Inhibitory Concentration
Minimum inhibitory concentrations (MICs) for gentamicin (EMD, Inc, Darmstadt, Germany) and streptomycin (Amresco, Solon, OH) were determined by broth microdilution according to the Clinical and Laboratory Standards Institute (CLSI).16 A control strain of P. aeruginosa, ATCC 27853, was included as a control. Data interpretation was based on CLSI 2018 clinical breakpoints.17
Time-Kill Assay in Optisol-GS
Time-kill kinetics was determined for a representative Achromobacter spp. strain isolated from the contaminated eyewash solution. The isolate was incubated in brain heart infusion broth (Difco Laboratories, Detroit, MI) overnight at 37°C with shaking (200 rpm). This solution was diluted 1:100 in fresh brain heart infusion broth and cultured to mid-log phase (OD600 = 0.5), washed 3 times, and resuspended in phosphate-buffered saline. The inoculum was resuspended in pure Optisol-GS solution (Bausch & Lomb, Inc, Rochester, NY) to a final concentration of approximately 1 to 2 × 106 CFU/mL and incubated at 37°C and 4°C (to mimic the storage conditions). Serial dilutions were plated at 0, 2, 4, 18, and 24 hours after incubation.
RESULTS
The peripheral corneal donor tissue that remains after trephination of the central cornea is commonly referred to as corneal “donor rims.”18 It is standard practice at MEE to culture the donor rims. The MEE clinical microbiology laboratory reported more culture-positive donor rims between July and December 2017, although there were no patient infections. During this period, 99 corneal donor rims were routinely cultured for bacteria and fungi, with 14 (14.1%) yielding at least 1 organism (Fig. 1). In the preceding 6 months (January through June 2017), the rate of culture positive corneal rims was 1.9%. Culture-positive corneal rims peaked in October of 2017. Unexpectedly, organisms growing from these rims (11/14, 78.6%) included uncommon NF-GNB phenotypically identified as closely related bacteria belonging to the genera Achromobacter (n = 3), Alcaligenes (n = 3), Ralstonia (n = 2), and Stenotrophomonas (n = 1), and Pseudomonas (n = 2). The remaining 3 positive donor rims grew α-hemolytic streptococci (n = 2) and an unidentified yeast (n = 1). Molecular identification performed on 8 (of 11) available NF-GNB isolates proved that all belonged to the genus Achromobacter (Table 1).
FIGURE 1.

Positivity of donor corneal rim cultures from July to December 2017. Among the 99 donor corneal rim cultures, 14 donor rims (14/99, 14.1%) were positive with the highest rate in October. (The full color version of this figure can be found online at www.corneajrnl.com.)
TABLE 1.
Identification and Susceptibilities of NF-GNB Growing Corneal Rim Cultures
| Case No. | Phenotypic ID | 16S rDNA ID | Amikacin | Gentamicin | Tobramycin | Levofloxacin |
|---|---|---|---|---|---|---|
| 1 | Alcaligenes spp. | Achromobacter spp. | I | R | R | S |
| 2 | Stenotrophomonas maltophilia | Achromobacter spp. | ND | ND | ND | S |
| 3 | Alcaligenes spp. | Achromobacter spp. | I | R | R | S |
| 4 | Alcaligenes spp. | Achromobacter spp. | R | R | R | S |
| 5 | Achromobacter xylosoxidans | ND | R | R | R | S |
| 6 | Ralstonia pickettii | Achromobacter spp. | R | R | R | S |
| 7 | Pseudomonas spp. | ND | R | R | R | S |
| 8 | Pseudomonas spp. | ND | R | R | R | S |
| 9 | Achromobacter xylosoxidans | Achromobacter spp. | R | R | R | S |
| 10 | Ralstonia pickettii | Achromobacter spp. | R | R | R | S |
| 11 | Achromobacter xylosoxidans | Achromobacter spp. | R | R | R | S |
I, intermediate; ND, not determined; R, resistant; S, susceptible.
When the increased frequency of NF-GNB species was noted at MEE, the results were reported to the eye bank that had supplied the corneal tissue. At approximately the same time, in October 2017, a different eye bank had experienced a cluster of contamination similar to MEE. Their observations were reported to the EBAA, and an alert was issued by EBAA to all eye banks. An eyewash solution used to irrigate corneas before their storage in Optisol-GS was identified by the eye bank as a possible source of the contamination. Samples of the eyewash were cultured by an independent commercial laboratory that detected a contamination caused by NF-GNB organisms identified as Achromobacter spp. (data not shown). The packing company provided to the eye bank the pack lot numbers that contained the implicated eyewash lot. All of those implicated packs were removed immediately from the market on identification.15 The eye bank sent 6 bottles of the implicated eyewash solution to the MEE microbiology laboratory for additional analysis. These bottles also grew Achromobacter spp. (identification confirmed molecularly) at unexpectedly high concentration (3.4 × 105 ± 1.1 CFU/mL). The bacterial loads were stable for 2 months in solutions stored at room temperature (data not shown).
The susceptibility of the 11 NF-GNB isolates to various antibiotics in vitro is tabulated in Table 1. As tested by automated broth microdilution using the MicroScan WalkAway system, these isolates were nonsusceptible to aminoglycosides gentamicin, amikacin, and tobramycin but susceptible to levofloxacin as defined by CLSI breakpoints.17 All Achromobacter spp. isolates from 6 samples of contaminated eyewash solution had the same antibiotic susceptibility profile. Because Optisol-GS contains 100 μg/mL gentamicin and 200 μg/mL streptomycin, and the Achromobacter spp. isolates were able to survive during storage of the corneoscleral rims, we determined the MIC of a representative eyewash solution-derived Achromobacter spp. for these 2 antibiotics in Mueller-Hinton broth by microdilution. MIC values were determined to be 4 μg/mL for gentamicin and 16 μg/mL for streptomycin, which suggested that they might be killed during storage in Optisol-GS. We quantified bacterial killing in Optisol-GS at 4°C—the standard temperature used by eye banks to store donor corneas—by inoculating 106 CFU/mL in pure Optisol-GS solution. No bacteria were killed 4 hours after addition of bacteria, and there was only a 1-log reduction after 18 and 24 hours. Incubation of this representative Achromobacter spp. in Optisol-GS at 37°C, however, resulted in a 3-log reduction in viable cells after 4 hours of incubation and complete killing after 18 hours as shown in Figure 2. This indicates that, in Optisol-GS at 4°C, Achromobacter spp. is not in a physiological state where it is readily killed by gentamicin or streptomycin concentrations above the MIC.19
FIGURE 2.

Time-kill kinetics of Optisol-GS against Achromobacter spp. A suspension of Achromobacter spp. in Optisol-GS was incubated for 24 hours at 4°C (blue line) and at 37°C (orange line). A 10-fold serial dilution from 10−1 to 10−6 was performed and plated for each temperature at 0, 2, 4, 18, and 24 hours after incubation. Each dataset is the average CFU/mL value calculated from a triplicate. (The full color version of this figure can be found online at www.corneajrnl.com.)
Patients (n = 11) were transplanted with these corneas after penetrating keratoplasty (PKP) (n = 10) and Descemetstripping automated endothelial keratoplasty (n = 1) surgeries. Despite the high level of contamination found in the eyewash solution and the ability of Achromobacter spp. to cause eye infections,20 none of the patients who received donor rim culture-positive corneal tissues developed a postoperative infection caused by this agent. One patient experienced delayed reepithelialization that led to keratitis and culture-proven acute endophthalmitis (post-PKP) caused by an unrelated organism (α-hemolytic streptococci).
DISCUSSION
Postoperative infections are one the most feared complications of corneal transplant surgery because of the potentially sight-threatening consequences. Contaminated tissue can be the source of the infecting microbe, and this risk cannot be completely eliminated by existing preparation and storage procedures.2–4 In an effort to better manage these infections at early stages, many surgeons perform routine surveillance cultures from the remaining corneoscleral rims and/or their storage medium.
Between July and December 2017, the rate of donor rim contamination (14.1%) was much higher than typically seen at MEE, and most of the contaminated rims were positive for uncommon NF-GNB. Through molecular techniques, 8 of these NF-GNB isolates were determined to belong to the genus Achromobacter. This differed from the identification made through the automated method (MicroScan) in several cases, the latter identifying the Achromobacter as Alcaligenes, Ralstonia, or Stenotrophomonas, all closely related NF-GNBs. Cultures of representative bottles of the same lot number of eyewash used to irrigate donor eyes in the eye bank also grew Achromobacter spp. In February 2018, the FDA published a voluntary nationwide recall of the contaminated eyewash solution.15
Achromobacter spp. are aerobic NF-GNB, closely related to the genus Pseudomonas. Achromobacter spp. are ubiquitous in aqueous environments (such as well water, tap water, and swimming pools) and can be frequently found as a contaminant of contact lens storage cases and lenses.21–23 The species Achromobacter xylosoxidans is recognized as an important emerging nosocomial pathogen and has been isolated from multiple types of aqueous solutions in health care settings24,25 and from a mechanical ventilator and catheters.26,27 It is considered an opportunistic bacterium of limited virulence; however, in immunocompromised patients, it is associated with a wide range of infections including bacteremia, pneumonia, urinary and intraabdominal infections, eye and ear infections, osteomyelitis, and meningitis.28,29 In immunocompromised patients, these infections might be life threatening because Achromobacter spp. is a hard-to-treat multidrug-resistant organism.28 Strains of this genus might be resistant to most aminoglycosides, ampicillin, aztreonam, and most cephalosporins, whereas expressing variable resistance to quinolones and carbapenems.30 Currently, none of the commercially available eye tissue preservation media sold in North America contains an agent active against Gram-negative bacteria with all of these resistance profiles. That presents as an opportunity for further development of improved solutions with broader spectrum of activity.
NF-GNB are particularly capable of contaminating solutions that might come in contact with the eye because of their wide environmental distribution and resistance to antimicrobials. Organisms such as P. aeruginosa,31 Stenotrophomonas maltophilia,21 Burkholderia spp.,32 Acinetobacter spp.,33 have been implicated in outbreaks that resulted in severe ocular infections where the source was a contaminated eye product. Fortunately, none of the patients in our series developed a postoperative infection caused by the organism contaminating the transplanted corneas. One patient experienced delayed reepithelialization that led to keratitis and culture-proven acute endophthalmitis (post-PKP) caused by α-hemolytic streptococci not identified in the laboratory as a contaminant of the donor tissue. Patients who undergo corneal transplantation procedures at MEE are routinely prescribed topical fluoroquinolones postoperatively as prophylaxis, and the Achromobacter spp. isolates were susceptible to levofloxacin, so this prophylaxis might have been protective. On the other hand, positive corneal donor rim cultures are relatively common at centers across the country, yet postoperative infections are very rare; so, many factors might contribute to the frequent lack of correlation between donor rim cultures and clinical infection.
Corneoscleral donor tissue is stored at 4°C in Optisol-GS containing relatively high levels of gentamicin (100 μg/mL) and streptomycin (200 μg/mL). Based on MIC values determined in bacteriological medium for a representative isolate of Achromobacter spp. in this study, Optisol-GS would be expected to control contamination during storage but that was not the case. Antimicrobial agents that target fundamental metabolic processes, such as aminoglycosides, are effective against viable and metabolically active cells in a culture.34 Thus, low nutrient value combined with refrigeration might paradoxically increase the survival of bacteria in solutions containing preservatives or antibiotics.35 Others have observed reduced bactericidal activity of Optisol-GS at low temperature against common microbes of the eye and improved activity at higher temperature,36 as observed in this study. These results highlight a limitation to the effectiveness of Optisol-GS in limiting microbial contamination of donor rims during storage at the recommended temperature.
In conclusion, we found an uncommon Gram-negative pathogen as the major contaminant of donor rims at our institution over a 6-month period. This was probably the result of 2 events that took place during processing and storage. First, the supplying eye bank processed the donor corneas using a particular lot of eyewash solution that served as the common source of contamination. Second, contaminated rims were not decontaminated by Optisol-GS at the low temperature that is typically used for cornea donor tissue storage. Although many advances have been made in protocols for tissue preparation and storage, the risk of potential postoperative infections resulting from contaminated reagents used in processing donor eyes has not been eliminated. Our study demonstrates that processing and storage of corneal rims warrants additional improvements to further minimize the likelihood of corneal donor tissue contamination.
Acknowledgments
J. B. Ciolino was supported by 1R01EY026640-01A1.
Footnotes
The authors have no conflicts of interest to disclose.
REFERENCES
- 1.Schallhorn JM, Rose-Nussbaumer J. Current Concepts in the management of unique post-keratoplasty infections. Curr Ophthalmol Rep. 2015;3:184–191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hassan SS, Wilhelmus KR; Medical Review Subcommittee of the Eye Bank Association of America. Eye-banking risk factors for fungal endophthalmitis compared with bacterial endophthalmitis after corneal transplantation. Am J Ophthalmol. 2005;139:685–690. [DOI] [PubMed] [Google Scholar]
- 3.Cameron JA, Antonios SR, Cotter JB, et al. Endophthalmitis from contaminated donor corneas following penetrating keratoplasty. Arch Ophthalmol. 1991;109:54–59. [DOI] [PubMed] [Google Scholar]
- 4.Eye Bank Association of America. Medical Advisory Board Agenda. Adverse Reactions Reported to EBAA. Medical Advisory Board Meeting; June 20, 2003; Washington, DC. p. 15. [Google Scholar]
- 5.EBAA Procedures Manual [EBAA website]. Available at: https://restoresight.org/what-we-do/publications/medical-standards-procedures-manual. Accessed June 21, 2016.
- 6.Wiffen SJ, Weston BC, Maguire LJ, et al. The value of routine donor corneal rim cultures in penetrating keratoplasty. Arch Ophthalmol. 1997;115:719–724. [DOI] [PubMed] [Google Scholar]
- 7.Garg S, Said B, Farid M, et al. Prevalence of positive microbiology results from donor cornea tissue in different methods of corneal transplantation. Cornea. 2013;32:137–140. [DOI] [PubMed] [Google Scholar]
- 8.Farrell PL, Fan JT, Smith RE, et al. Donor cornea bacterial contamination. Cornea. 1991;10:381–386. [DOI] [PubMed] [Google Scholar]
- 9.Vajpayee RB, Sharma N, Sinha R, et al. Infectious keratitis following keratoplasty. Surv Ophthalmol. 2007;52:1–12. [DOI] [PubMed] [Google Scholar]
- 10.Keyhani K, Seedor JA, Shah MK, et al. The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005;24:288–291. [DOI] [PubMed] [Google Scholar]
- 11.Brothers KM, Shanks RMQ, Hurlbert S, et al. Association between fungal contamination and eye bank-prepared endothelial keratoplasty tissue: temperature-dependent risk factors and antifungal supplementation of Optisol-Gentamicin and Streptomycin. JAMA Ophthalmol. 2017; 135:1184–1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lindquist TD, Miller TD, Elsen JL, et al. Minimizing the risk of disease transmission during corneal tissue processing. Cornea. 2009;28:481–484. [DOI] [PubMed] [Google Scholar]
- 13.Sieck EA, Enzenauer RW, Cornell FM, et al. Contamination of K-Sol corneal storage medium with Propionibacterium acnes. Arch Ophthalmol. 1989;107:1023–1024. [DOI] [PubMed] [Google Scholar]
- 14.Moore PJ, Linnemann CC, Sanitato JJ, et al. Pneumococcal endophthalmitis after corneal transplantation: control by modification of harvesting techniques. Infect Control Hosp Epidemiol. 1989;10:102–105. [DOI] [PubMed] [Google Scholar]
- 15.Recalls, Market Withdrawals, & Safety Alerts [FDA website]. Available at: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/kareway-products-inc-issues-voluntary-nationwide-recall-gericare-eye-wash-due-complaints-received. Accessed February 6, 2018.
- 16.Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard—Ninth Edition. CLSI Document M07-A9. Wayne, PA: Clinical and Laboratory Standard Institutes; 2012. [Google Scholar]
- 17.Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. [Google Scholar]
- 18.Speakman JS, Jones JD. Corneal trephining for penetrating keratoplasty. Br J Ophthalmol. 1956;40:216–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8:423–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Spierer O, Monsalve PF, O’Brien TP, et al. Clinical Features, Antibiotic susceptibility profiles, and outcomes of infectious keratitis caused by Achromobacter xylosoxidans. Cornea. 2016;35:626–630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Furuhata K, Ishizaki N, Kawakami Y, et al. Bacterial contamination of stock solutions in storage cases for contact lens, and the disinfectant-resistance of isolates. Biocontrol Sci. 2010;15:81–85. [DOI] [PubMed] [Google Scholar]
- 22.Kilvington S, Shovlin J, Nikolic M. Identification and susceptibility to multipurpose disinfectant solutions of bacteria isolated from contact lens storage cases of patients with corneal infiltrative events. Cont Lens Anterior Eye. 2013;36:294–298. [DOI] [PubMed] [Google Scholar]
- 23.Wiley L, Bridge DR, Wiley LA, et al. Bacterial biofilm diversity in contact lens-related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia. Invest Ophthalmol Vis Sci. 2012;53:3896–3905. [DOI] [PubMed] [Google Scholar]
- 24.Reverdy ME, Freney J, Fleurette J, et al. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol. 1984;19:140–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Reina J, Antich M, Siquier B, et al. Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution. J Clin Pathol. 1988;41:920–921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chandrasekar PH, Arathoon E, Levine DP. Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection. 1986;14:279–282. [DOI] [PubMed] [Google Scholar]
- 27.Gómez-Cerezo J, Suárez I, Ríos JJ, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003;22:360–363. [DOI] [PubMed] [Google Scholar]
- 28.Teng SO, Ou TY, Hsieh YC, et al. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans. J Microbiol Immunol Infect. 2009;42:176–180. [PubMed] [Google Scholar]
- 29.Reddy AK, Garg P, Shah V, et al. Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans. Cornea. 2009;28:1100–1103. [DOI] [PubMed] [Google Scholar]
- 30.Yamamoto M, Nagao M, Hotta G, et al. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans. J Antimicrob Chemother. 2012;67:2110–2113. [DOI] [PubMed] [Google Scholar]
- 31.Vazirani J, Wurity S, Ali MH. Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology. 2015;122:2110–2114. [DOI] [PubMed] [Google Scholar]
- 32.Holland SP, Mathias RG, Morck DW, et al. Diffuse lamellar keratitis related to endotoxins released from sterilizer reservoir biofilms. Ophthalmology. 2000;107:1227–1233; discussion 1233–1234. [DOI] [PubMed] [Google Scholar]
- 33.Corrigan KM, Harmis NY, Willcox MD. Association of acinetobacter species with contact lens-induced adverse responses. Cornea. 2001;20:463–466. [DOI] [PubMed] [Google Scholar]
- 34.Rahmati-Bahram A, Magee JT, Jackson SK. Effect of temperature on aminoglycoside binding sites in Stenotrophomonas maltophilia. J Antimicrob Chemother. 1997;39:19–24. [DOI] [PubMed] [Google Scholar]
- 35.Bongaerts GPA, Jansen LE. Why refrigeration paradoxically prolongs bacterial survival in the presence of preservatives. Clin Infect Dis. 2003;37:1403. [DOI] [PubMed] [Google Scholar]
- 36.Kapur R, Tu EY, Pendland SL, et al. The effect of temperature on the antimicrobial activity of Optisol-GS. Cornea. 2006;25:319–324. [DOI] [PubMed] [Google Scholar]
